Janssen

Jan 23, 2018

ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen

Jan 03, 2018

Dr. Paul Janssen Award for Biomedical Research Issues 2018 Call for Nominations to Celebrate Champions of Science

Dec 21, 2017

Ionis Pharmaceuticals Announces The Initiation Of A Clinical Study Of Its First Orally Delivered Antisense Drug For The Treatment Of Gastrointestinal Disorders

Sep 11, 2017

Janssen to Discontinue Hepatitis C Development Program

Aug 27, 2017

XARELTO® (rivaroxaban) Significantly Reduced Major Cardiovascular Events in Patients with Stable Coronary and Peripheral Artery Disease in Pivotal Phase 3 Study

Jun 01, 2017

Janssen Announces Submissions in Europe and US for Single-Tablet Regimen of Dolutegravir plus Rilpivirine - the First Two-Drug HIV Maintenance Treatment